Current Headlines

31. BioOutsource Opens New Facility In Cambridge, Massachusetts
    4/23/2013

    BioOutsource Ltd. (“BioOutsource”), a global leader in the biological analysis of biosimilar molecules for the biopharmaceutical industry, today announced the opening of a new facility in Cambridge, Massachusetts, the company’s first in the United States.

32. AMRI And Ono Broaden SMARTSOURCING™ Collaboration
    4/23/2013

    AMRI announced recently that it has entered into a new five-year service agreement with Ono Pharmaceutical Company, Ltd., a pharmaceutical company headquartered in Osaka, Japan. Under the terms of the agreement, AMRI may provide a range of services from early drug discovery to cGMP manufacturing.

33. Global Vision Launches QCanywhere The First Cloud-Based Business Apps To Inspect Documents, Artwork And Print
    4/23/2013

    Global Vision, the industry leader in the development of automated proofreading solutions, recently announced the launch of QCanywhere, the industry’s first SaaS tool for quality control. QCanywhere addresses the need for company-wide access to quality control solutions to help protect brand integrity. 

34. DSM And DecImmune Therapeutics Sign Agreement To Develop N2 Pathway Blocking Antibody
    4/22/2013

    DSM Pharmaceutical Products, the custom manufacturing and technology business of Royal DSM, announced recently that it has signed an agreement with venture capital funded DecImmune Therapeutics of Cambridge, Massachusetts, USA.

35. DSM Announces June Opening Of New cGMP Biopharmaceutical Manufacturing Operation In Brisbane, Australia
    4/22/2013

    DSM Pharmaceutical Products, the custom manufacturing and technology business of Royal DSM, announced recently that their new cGMP custom biopharmaceutical manufacturing 'biologics plant of the future' will open in June 2013.

36. Anti-HIV Therapy Appears To Protect Children's Hearts, NIH Network Study Shows
    4/22/2013

    For children who have had HIV-1 infection since birth, the combination drug therapies now used to treat HIV appear to protect against the heart damage seen before combination therapies were available, according to researchers in a National Institutes of Health network study.

37. Fujifilm Diosynth Biotechnologies Commissions New Cell Banking Facility At Billingham, UK Site
    4/22/2013

    ujifilm Diosynth Biotechnologies has announced that it has commissioned on time its new mammalian cGMP Cell Banking Facility (CBF) at its Billingham, UK site.

38. ATMI Offers Helium Integrity Testing System In Point Of Use Format For Validation Of Single-Use Bags And Assemblies
    4/22/2013

    ATMI, Inc., a global technology company and leader in single-use bioprocess solutions, recently announced that its proprietary helium integrity testing (HIT) system has been made available to end-users for on-site application.

39. BioTek Instruments Wins Governor's Award For Outstanding Workplace Safety
    4/17/2013

    The Vermont Safety & Health Council, and the Vermont Small Business Development Center recently presented BioTek with the 2013 "Governor's Award for Outstanding Workplace Safety" in the Large Business category at a ceremony in South Burlington, VT.

40. ATMI Debuts Integrity® LevMixer® 3 At INTERPHEX
    4/17/2013

    ATMI, Inc. (Nasdaq:ATMI), a global technology company and leader in single-use bioprocess solutions, today unveiled the third generation of its Integrity® LevMixer® system with full remote control capability and real-time speed reading.